Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Cybin
CYBN
Cybin
Cybin will leverage its 70 patents for breakthroughs in holistic depression treatment
BR
BrightSide
Invested
Community Contributor
Published
13 Feb 25
Updated
13 Feb 25
6
Set Fair Value
0
votes
1
Share
BrightSide
's Fair Value
US$0
n/a
intrinsic discount
13 Feb
US$7.56
Loading
1Y
-24.9%
7D
-2.3%
Author's Valuation
US$0
n/a
intrinsic discount
BrightSide's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
BrightSide
's
Fair Value
US$0
n/a
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
-104m
864k
2020
2022
2024
2025
2026
2028
2030
Revenue CA$0
Earnings CA$0
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
68.49%
Pharma revenue growth rate
1.13%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.40%
Calculation
CA$0
Earnings '30
x
22.08x
PE Ratio '30
=
CA$0
Market Cap '30
CA$0
Market Cap '30
/
27.05m
No. shares '30
=
CA$0
Share Price '30
CA$0
Share Price '30
Discounted to 2025 @ 6.21% p.a.
=
CA$0
Fair Value '25
CA$0
Fair Value '25
Converted to USD @ 0.7001 CAD/USD Exchange Rate
=
US$0
Fair Value '25
